贝格列净(EGT1442)产品是Bexagliflozin is a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor with IC₅₀ values of 5.6 µM and 2 nM for human SGLT1 and SGLT2, respectively. Bexagliflozin dose-dependently reduces HbA(1c) and blood glucose concentration without affecting body mass or insulin level.